publicações selecionadas
-
artigo académico
- Inflammatory Cells in Adipose Tissue and Skeletal Muscle of Patients with Peripheral Arterial Disease or Chronic Venous Disease: A Prospective, Observational, and Histological Study. Journal of Cardiovascular Development and Disease. 2024
- Higher Levels of Cytokines in Patients with Chronic Limb-Threatening Ischemia. Annals of Vascular Surgery. 2024
- Cisplatin-Resistant Urothelial Bladder Cancer Cells Undergo Metabolic Reprogramming beyond the Warburg Effect. Cancers. 2024
- Effects of Lactate Transport Inhibition by AZD3965 in Muscle-Invasive Urothelial Bladder Cancer. Pharmaceutics. 2023
- Exosomes modified with anti-MEK1 siRNA lead to an effective silencing of triple negative breast cancer cells. Biomaterials Advances. 2023
- Exploring the Diversity of Visceral, Subcutaneous and Perivascular Adipose Tissue in a Vascular Surgery Population. Journal of Cardiovascular Development and Disease. 2023
- Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: a pilot study. Journal of Applied Oral Science. 2023
- Targeting monocarboxylate transporters (MCTs) in cancer: How close are we to the clinics?. Seminars in Cancer Biology. 2023
- Prognostic Value of Monocarboxylate Transporter 1 Overexpression in Cancer: A Systematic Review. International Journal of Molecular Sciences. 2023
- Clinical and Prognostic Impact of the Warburg Effect in Esophageal Carcinoma: Monocarboxylate Transporters as Candidates for Therapeutic Targeting. Pathobiology. 2023
- Lactate Beyond a Waste Metabolite: Metabolic Affairs and Signaling in Malignancy. Frontiers in Oncology. 2020
- Competitive glucose metabolism as a target to boost bladder cancer immunotherapy. Nature Reviews Urology. 2020
- 10.1038/s41585-019-0263-6. Nature Reviews Urology. 2020
- Urothelial bladder cancer progression: lessons learned from the bench. Journal of Cancer Metastasis and Treatment. 2015
- Lymphangiogenic VEGF-C and VEGFR-3 expression in genetically characterised gastrointestinal stromal tumours.. Histology and Histopathology. 2011
- The effects of sirolimus on urothelial lesions chemically induced in ICR mice by BBN.. Anticancer Research. 2009
- Is DNA content alteration a consequence of proliferative and differentiation changes in urothelial bladder tumours?. Ata Urológica Portuguesa. 2003
-
artigo de conferência
-
artigo de revista
- Glucose Metabolism Reprogramming in Bladder Cancer: Hexokinase 2 (HK2) as Prognostic Biomarker and Target for Bladder Cancer Therapy. Cancers. 2023
- In Vivo Anticancer Activity of AZD3965: A Systematic Review. Biomolecules. 2021
- Clinical significance of metabolism-related biomarkers in non-Hodgkin lymphoma - MCT1 as potential target in diffuse large B cell lymphoma. Cellular Oncology. 2019
- Metabolic coupling in urothelial bladder cancer compartments and its correlation to tumor aggressiveness. Cell Cycle. 2016
- CD147 and MCT1 - potential partners in bladder cancer aggressiveness and cisplatin resistance. Molecular Carcinogenesis. 2015
- Evolving hallmarks in urothelial bladder cancer: unveiling potential biomarkers. Acta Urológica Portuguesa. 2015
- Urothelial bladder cancer progression: lessons learned from the bench. Journal of Cancer Metastasis and Treatment. 2014
- Phospho-mTOR in non-tumour and tumour bladder urothelium: Pattern of expression and impact on urothelial bladder cancer patients. Oncology Letters. 2014
- Low RKIP expression associates with poor prognosis in bladder cancer patients. Virchows Archiv. 2013
- Lymphangiogenic VEGF-C and VEGFR-3 expression in genetically characterised gastrointestinal stromal tumours. Histology and Histopathology. 2011
- CD147 overexpression allows an accurate discrimination of bladder cancer patients' prognosis. Ejso. 2011
- The aggressiveness of urothelial carcinoma depends to a large extent on lymphovascular invasion - The prognostic contribution of related molecular markers. Histopathology. 2009
-
capítulo de livro
- Lactate and lactate transporters as key players in the maintenance of the Warburg effect 2020
- New horizons on pH regulators as cancer biomarkers and targets for pharmacological intervention 2020
- Targeting Metabolic Reprogramming as an Anti- Cancer Strategy: Aiming at Monocarboxylate Transporters 2015
- Angiogenesis, Lymphangiogenesis and Lymphovascular Invasion: Prognostic Impact for Bladder Cancer Patients 2012
-
documento
- Comparative study of adipose tissue characteristics between claudication and critical limb threatening ischemia 2024
- Effects of lactate transport inhibition by AZD3965 in muscle-invasive urothelial bladder cancer 2023
- Exploring the differences in skeletal muscle between patients with chronic limb-threatening ischemia and claudication 2023
- Prognostic Value of Monocarboxylate Transporter 1 Overexpression in Cancer: A Systematic Review 2023
- Farmacologia pré-clínica do inibidor do transportador de monocarboxilatos 1, AZD3965, no cancro da bexiga 2022
- Hexokinase II (HKII) as prognostic biomarker and target for bladder cancer therapy 2022
- GPR81 in Bladder Cancer - Functional Insights 2022
- Pre-clinical pharmacology of the monocarboxylate transporter 1 inhibitor AZD3965 in bladder cancer 2022
- Exosome-mediated MEK1 silencing is a promising approach against triple negative breast cancer regression 2022
- Exossomas modificados para o desenvolvimento de novas terapias para cancro de mama triplo negativo 2021
- Hexokinase II (HKII) is a prognostic biomarker for bladder cancer patients: Antitumoral activity of the HKII inhibitor 2-deoxy-D-glucose 2021
- Upregulation of Hexokinase II (HKII) impacts survival of bladder cancer patients: Effects of HKII inhibition by 2-deoxy-D-glucose 2021
- Metabolic remodelling in cisplatin-resistant bladder cancer 2020
- Characterization of glycolytic metabolism of oesophageal carcinomas and evaluation of its potential as therapeutic target 2019
- Cisplatin-resistant urothelial bladder cancer cells undergo metabolic reprogramming 2019
- Characterization of glycolytic metabolism of esophageal carcinomas and evaluation of its potential as therapeutic target. 2019
- Cisplatin-resistant urothelial bladder cancer cells undergo metabolic reprogramming. 2019
- The metabolic coupling among urothelial bladder cancer compartments predicts tumour aggressiveness and chemoresistance 2015
- CD147 and MCT1: Potential partners in bladder cancer aggressiveness and cisplatin resistance 2013
- RKIP downregulation associates with poor prognosis in bladder cancer patients 2013
- RKIP downregulation associates with poor prognosis in bladder cancer patients 2012
- CD147 overexpression allows an accurate discrimination of bladder cancer patients' prognosis 2011
- Estudo da Imunoexpressão dos Grupos Sanguíneos ABO em Carcinomas Uroteliais Superficiais e Invasores 2002
-
livro
-
teses
- Translating biology into clinic: new insights on prognostic and predictive biomarkers for urothelial bladder carcinoma 2013
- Role of Lymphangiogenesis and Angiogenesis in Advanced Bladder Tumors 2008
- Phenotypic (and Genotypic) Alterations in Urothelial Bladder Carcinomas, and their Prognostic Role 2001